Venrock Healthcare Capital Partners III, L.P. - 25 Mar 2026 Form 4 Insider Report for KalVista Pharmaceuticals, Inc. (KALV)

Reporting relationship
10%+ Owner
Issuer ticker
KALV
Reported as of
25 Mar 2026
Net transaction value
-$3,691,148
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
27 Mar 2026, 17:50:10 UTC
Prior SEC filing
11 Apr 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Venrock Healthcare Capital Partners III, L.P., By: VHCP Management III, LLC, Its: General Partner, By: /s/ Sherman G. Souther, Authorized Signatory

Key filing fact

Venrock Healthcare Capital Partners III, L.P. filed Form 4 for KalVista Pharmaceuticals, Inc. (KALV) on 27 Mar 2026.

Key facts

  • This page summarizes Venrock Healthcare Capital Partners III, L.P.'s Form 4 filing for KalVista Pharmaceuticals, Inc. (KALV).
  • 5 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 27 Mar 2026, 17:50.

Change

  • Previous filing in this sequence was filed on 11 Apr 2025.
  • Current net transaction value: -$3,691,148.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (7)

CIK 0001738048 Primary reporting owner

Venrock Healthcare Capital Partners III, L.P.

Relationship
10%+ Owner
Address
C/O VENROCK, 7 BRYANT PARK, 23RD FLOOR, NEW YORK
Signature
Venrock Healthcare Capital Partners III, L.P., By: VHCP Management III, LLC, Its: General Partner, By: /s/ Sherman G. Souther, Authorized Signatory
Signature date
27 Mar 2026
CIK 0001750761

VHCP Co-Investment Holdings III, LLC

Relationship
10%+ Owner
Address
C/O VENROCK, 7 BRYANT PARK, 23RD FLOOR, NEW YORK
Signature
VHCP Co-Investment Holdings III, LLC, By: VHCP Management III, LLC, Its: Manager, By: /s/ Sherman G. Souther, Authorized Signatory
Signature date
27 Mar 2026
CIK 0001808518

VHCP Management EG, LLC

Relationship
10%+ Owner
Address
C/O VENROCK, 7 BRYANT PARK, 23RD FLOOR, NEW YORK
Signature
VHCP Management III, LLC, By: /s/ Sherman G. Souther, Authorized Signatory
Signature date
27 Mar 2026
CIK 0001808512

Venrock Healthcare Capital Partners EG, L.P.

Relationship
10%+ Owner
Address
C/O VENROCK, 7 BRYANT PARK, 23RD FLOOR, NEW YORK
Signature
Venrock Healthcare Capital Partners EG, L.P., By: VHCP Management EG, LLC, Its: General Partner, By: /s/ Sherman G. Souther, Authorized Signatory
Signature date
27 Mar 2026
CIK 0001738053

VHCP Management III, LLC

Relationship
10%+ Owner
Address
C/O VENROCK, 7 BRYANT PARK, 23RD FLOOR, NEW YORK
Signature
VHCP Management EG, LLC, By: /s/ Sherman G. Souther, Authorized Signatory
Signature date
27 Mar 2026
CIK 0001615979

Koh Bong Y

Relationship
10%+ Owner
Address
C/O VENROCK, 7 BRYANT PARK, 23RD FLOOR, NEW YORK
Signature
Bong Koh, By: /s/ Sherman G. Souther, Attorney-in-fact
Signature date
27 Mar 2026
CIK 0001698082

Shah Nimish P

Relationship
10%+ Owner
Address
C/O VENROCK, 7 BRYANT PARK, 23RD FLOOR, NEW YORK
Signature
Nimish Shah, By: /s/ Sherman G. Souther, Attorney-in-fact
Signature date
27 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

KALV transaction

Common Stock

Sale

Transaction value
$2,957,521
Shares
-174,485
Change %
-3.3%
Price
$16.95
Shares after
5,129,500
Date
25 Mar 2026
Ownership
By Funds
Footnotes
F1, F2, F3
KALV transaction

Common Stock

Sale

Transaction value
$2,957,521
Shares
-174,485
Change %
-3.3%
Price
$16.95
Shares after
5,129,500
Date
25 Mar 2026
Ownership
By Funds
Footnotes
F1, F2, F3
KALV transaction

Common Stock

Sale

Transaction value
$2,957,521
Shares
-174,485
Change %
-3.3%
Price
$16.95
Shares after
5,129,500
Date
25 Mar 2026
Ownership
By Funds
Footnotes
F1, F2, F3
KALV transaction

Common Stock

Sale

Transaction value
$2,957,521
Shares
-174,485
Change %
-3.3%
Price
$16.95
Shares after
5,129,500
Date
25 Mar 2026
Ownership
By Funds
Footnotes
F1, F2, F3
KALV transaction

Common Stock

Sale

Transaction value
$2,957,521
Shares
-174,485
Change %
-3.3%
Price
$16.95
Shares after
5,129,500
Date
25 Mar 2026
Ownership
By Funds
Footnotes
F1, F2, F3
KALV transaction

Common Stock

Sale

Transaction value
$2,957,521
Shares
-174,485
Change %
-3.3%
Price
$16.95
Shares after
5,129,500
Date
25 Mar 2026
Ownership
By Funds
Footnotes
F1, F2, F3
KALV transaction

Common Stock

Sale

Transaction value
$2,957,521
Shares
-174,485
Change %
-3.3%
Price
$16.95
Shares after
5,129,500
Date
25 Mar 2026
Ownership
By Funds
Footnotes
F1, F2, F3
KALV transaction

Common Stock

Sale

Transaction value
$2,805
Shares
-160
Change %
-0%
Price
$17.53
Shares after
5,129,340
Date
25 Mar 2026
Ownership
By Funds
Footnotes
F3, F4, F5
KALV transaction

Common Stock

Sale

Transaction value
$2,805
Shares
-160
Change %
-0%
Price
$17.53
Shares after
5,129,340
Date
25 Mar 2026
Ownership
By Funds
Footnotes
F3, F4, F5
KALV transaction

Common Stock

Sale

Transaction value
$2,805
Shares
-160
Change %
-0%
Price
$17.53
Shares after
5,129,340
Date
25 Mar 2026
Ownership
By Funds
Footnotes
F3, F4, F5
KALV transaction

Common Stock

Sale

Transaction value
$2,805
Shares
-160
Change %
-0%
Price
$17.53
Shares after
5,129,340
Date
25 Mar 2026
Ownership
By Funds
Footnotes
F3, F4, F5
KALV transaction

Common Stock

Sale

Transaction value
$2,805
Shares
-160
Change %
-0%
Price
$17.53
Shares after
5,129,340
Date
25 Mar 2026
Ownership
By Funds
Footnotes
F3, F4, F5
KALV transaction

Common Stock

Sale

Transaction value
$2,805
Shares
-160
Change %
-0%
Price
$17.53
Shares after
5,129,340
Date
25 Mar 2026
Ownership
By Funds
Footnotes
F3, F4, F5
KALV transaction

Common Stock

Sale

Transaction value
$2,805
Shares
-160
Change %
-0%
Price
$17.53
Shares after
5,129,340
Date
25 Mar 2026
Ownership
By Funds
Footnotes
F3, F4, F5
KALV transaction

Common Stock

Sale

Transaction value
$379,815
Shares
-21,386
Change %
-0.42%
Price
$17.76
Shares after
5,107,954
Date
26 Mar 2026
Ownership
By Funds
Footnotes
F3, F6, F7
KALV transaction

Common Stock

Sale

Transaction value
$379,815
Shares
-21,386
Change %
-0.42%
Price
$17.76
Shares after
5,107,954
Date
26 Mar 2026
Ownership
By Funds
Footnotes
F3, F6, F7
KALV transaction

Common Stock

Sale

Transaction value
$379,815
Shares
-21,386
Change %
-0.42%
Price
$17.76
Shares after
5,107,954
Date
26 Mar 2026
Ownership
By Funds
Footnotes
F3, F6, F7
KALV transaction

Common Stock

Sale

Transaction value
$379,815
Shares
-21,386
Change %
-0.42%
Price
$17.76
Shares after
5,107,954
Date
26 Mar 2026
Ownership
By Funds
Footnotes
F3, F6, F7
KALV transaction

Common Stock

Sale

Transaction value
$379,815
Shares
-21,386
Change %
-0.42%
Price
$17.76
Shares after
5,107,954
Date
26 Mar 2026
Ownership
By Funds
Footnotes
F3, F6, F7
KALV transaction

Common Stock

Sale

Transaction value
$379,815
Shares
-21,386
Change %
-0.42%
Price
$17.76
Shares after
5,107,954
Date
26 Mar 2026
Ownership
By Funds
Footnotes
F3, F6, F7
KALV transaction

Common Stock

Sale

Transaction value
$379,815
Shares
-21,386
Change %
-0.42%
Price
$17.76
Shares after
5,107,954
Date
26 Mar 2026
Ownership
By Funds
Footnotes
F3, F6, F7
KALV transaction

Common Stock

Sale

Transaction value
$290,148
Shares
-15,417
Change %
-0.3%
Price
$18.82
Shares after
5,092,537
Date
26 Mar 2026
Ownership
By Funds
Footnotes
F3, F8, F9
KALV transaction

Common Stock

Sale

Transaction value
$290,148
Shares
-15,417
Change %
-0.3%
Price
$18.82
Shares after
5,092,537
Date
26 Mar 2026
Ownership
By Funds
Footnotes
F3, F8, F9
KALV transaction

Common Stock

Sale

Transaction value
$290,148
Shares
-15,417
Change %
-0.3%
Price
$18.82
Shares after
5,092,537
Date
26 Mar 2026
Ownership
By Funds
Footnotes
F3, F8, F9
KALV transaction

Common Stock

Sale

Transaction value
$290,148
Shares
-15,417
Change %
-0.3%
Price
$18.82
Shares after
5,092,537
Date
26 Mar 2026
Ownership
By Funds
Footnotes
F3, F8, F9
KALV transaction

Common Stock

Sale

Transaction value
$290,148
Shares
-15,417
Change %
-0.3%
Price
$18.82
Shares after
5,092,537
Date
26 Mar 2026
Ownership
By Funds
Footnotes
F3, F8, F9
KALV transaction

Common Stock

Sale

Transaction value
$290,148
Shares
-15,417
Change %
-0.3%
Price
$18.82
Shares after
5,092,537
Date
26 Mar 2026
Ownership
By Funds
Footnotes
F3, F8, F9
KALV transaction

Common Stock

Sale

Transaction value
$290,148
Shares
-15,417
Change %
-0.3%
Price
$18.82
Shares after
5,092,537
Date
26 Mar 2026
Ownership
By Funds
Footnotes
F3, F8, F9
KALV transaction

Common Stock

Sale

Transaction value
$60,859
Shares
-3,183
Change %
-0.06%
Price
$19.12
Shares after
5,089,354
Date
26 Mar 2026
Ownership
By Funds
Footnotes
F3, F10, F11
KALV transaction

Common Stock

Sale

Transaction value
$60,859
Shares
-3,183
Change %
-0.06%
Price
$19.12
Shares after
5,089,354
Date
26 Mar 2026
Ownership
By Funds
Footnotes
F3, F10, F11
KALV transaction

Common Stock

Sale

Transaction value
$60,859
Shares
-3,183
Change %
-0.06%
Price
$19.12
Shares after
5,089,354
Date
26 Mar 2026
Ownership
By Funds
Footnotes
F3, F10, F11
KALV transaction

Common Stock

Sale

Transaction value
$60,859
Shares
-3,183
Change %
-0.06%
Price
$19.12
Shares after
5,089,354
Date
26 Mar 2026
Ownership
By Funds
Footnotes
F3, F10, F11
KALV transaction

Common Stock

Sale

Transaction value
$60,859
Shares
-3,183
Change %
-0.06%
Price
$19.12
Shares after
5,089,354
Date
26 Mar 2026
Ownership
By Funds
Footnotes
F3, F10, F11
KALV transaction

Common Stock

Sale

Transaction value
$60,859
Shares
-3,183
Change %
-0.06%
Price
$19.12
Shares after
5,089,354
Date
26 Mar 2026
Ownership
By Funds
Footnotes
F3, F10, F11
KALV transaction

Common Stock

Sale

Transaction value
$60,859
Shares
-3,183
Change %
-0.06%
Price
$19.12
Shares after
5,089,354
Date
26 Mar 2026
Ownership
By Funds
Footnotes
F3, F10, F11
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Venrock Healthcare Capital Partners III, L.P. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 11 footnotes

Footnote F1

The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $16.51 to $17.50 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.

Footnote F2

Consists of (i) 1,105,126 shares held by Venrock Healthcare Capital Partners III, L.P. ("VHCP3"); (ii) 110,550 shares held by VHCP Co-Investment Holdings III,LLC ("VHCP Co-3"); and (iii) 3,913,824 shares held by Venrock Healthcare Capital Partners EG, L.P. ("VHCP EG").

Footnote F3

VHCP Management III, LLC ("VHCPM3") is the general partner of VHCP3 and the manager of VHCP Co-3 and may be deemed to beneficially own these securities. VHCP Management EG, LLC ("VHCPMEG") is the general partner of VHCPEG and may be deemed to beneficially own these securities. Bong Koh and Nimish Shah are the voting members of VHCPM3 and VHCPMEG and may be deemed to beneficially own these securities. Each of VHCPM3, VHCPMEG and Messrs. Koh and Shah expressly disclaims beneficial ownership over these securities except to the extent of its or his indirect pecuniary interest therein.

Footnote F4

The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $17.51 to $17.55 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.

Footnote F5

Consists of (i) 1,105,092 shares held by VHCP3; (ii) 110,547 shares held by VHCP Co-3; and (iii) 3,913,701 shares held by VHCP EG.

Footnote F6

The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $17.07 to $18.06 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.

Footnote F7

Consists of (i) 1,100,485 shares held by VHCP3; (ii) 110,085 shares held by VHCP Co-3; and (iii) 3,897,384 shares held by VHCP EG.

Footnote F8

The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $18.07 to $19.06 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.

Footnote F9

Consists of (i) 1,097,164 shares held by VHCP3; (ii) 109,752 shares held by VHCP Co-3; and (iii) 3,885,621 shares held by VHCP EG.

Footnote F10

The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $19.07 to $19.25 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.

Footnote F11

Consists of (i) 1,096,478 shares held by VHCP3; (ii) 109,684 shares held by VHCP Co-3; and (iii) 3,883,192 shares held by VHCP EG.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .